Detalhe da pesquisa
1.
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Lancet Oncol
; 24(9): 1029-1041, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657462
2.
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
Blood
; 132(19): 2026-2039, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082494
3.
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas.
Blood
; 127(7): 858-68, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603836
4.
2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region.
J Immunol
; 188(7): 3294-306, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357631
5.
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.
Clin Cancer Res
; 28(15): 3256-3267, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583555
6.
Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients.
Nat Commun
; 11(1): 5551, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33144586
7.
BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress.
Cancer Discov
; 9(5): 662-679, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30777872
8.
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
Nat Commun
; 8: 14290, 2017 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28134252
9.
A dioxin response element in the multiple cloning site of the pGL3 luciferase reporter influences transcriptional activity.
Toxicol In Vitro
; 26(6): 979-84, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22652426
10.
Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
Nat Commun
; 8: 14747, 2017 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28218232